These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9812530)

  • 1. [Molecular biologic markers and cancer risk assessment].
    Zi XL; Yu SZ; Dong CH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):244-6. PubMed ID: 9812530
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of biomarkers in the assessment of health risk from environmental exposure to chemical carcinogens].
    Kostka G
    Rocz Panstw Zakl Hig; 2003; 54 Suppl():30-1. PubMed ID: 12884497
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular definition of carcinogenetic risk].
    Hubert-Habart M
    Bull Cancer; 1993 Jul; 80(7):561-6. PubMed ID: 8204935
    [No Abstract]   [Full Text] [Related]  

  • 4. New trends in molecular epidemiology. Introduction.
    Montesano R; Dogliotti E; Pasquini P
    Ann Ist Super Sanita; 1996; 32(1):1-2. PubMed ID: 8967712
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular epidemiology.
    Shields PG
    Prog Clin Biol Res; 1996; 395():141-57. PubMed ID: 8895987
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular epidemiology: new rules for new tools?
    Merlo DF; Sormani MP; Bruzzi P
    Mutat Res; 2006 Aug; 600(1-2):3-11. PubMed ID: 16843503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible relationship between onco/suppressor gene expression and carcinogen exposure in vivo: evaluation of a potential biomarker in preventive and predictive medicine.
    Ember I; Gyöngyi Z; Kiss I; Ghodratollah N; Arany I
    Anticancer Res; 2002; 22(4):2109-16. PubMed ID: 12174891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic data and cancer risk assessment: the need for quantitative molecular endpoints.
    Preston RJ
    Environ Mol Mutagen; 2005; 45(2-3):214-21. PubMed ID: 15645441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The risk assessment of cancer morbidity in the joint action of carcinogens].
    Shaĭkina OI; Shaĭkin AB; Kon'shina LG
    Gig Sanit; 1999; (1):41-3. PubMed ID: 10199078
    [No Abstract]   [Full Text] [Related]  

  • 10. A molecular epidemiological approach to health risk assessment of urban air pollution.
    Hrelia P; Maffei F; Angelini S; Forti GC
    Toxicol Lett; 2004 Apr; 149(1-3):261-7. PubMed ID: 15093272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Environmental mutagenesis and use of biomarkers in cancer risk prediction].
    Cuenca P; Ramírez V
    Rev Biol Trop; 2004 Sep; 52(3):585-90. PubMed ID: 17361552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogen-DNA adducts as a biomarker for cancer risk.
    Rundle A
    Mutat Res; 2006 Aug; 600(1-2):23-36. PubMed ID: 16824556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of low level arsenic exposure for evaluating human cancer risks in a US population.
    Karagas MR; Le CX; Morris S; Blum J; Lu X; Spate V; Carey M; Stannard V; Klaue B; Tosteson TD
    Int J Occup Med Environ Health; 2001; 14(2):171-5. PubMed ID: 11548067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
    Shields PG
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative epidemiology: from risk assessment to outcome prediction.
    Spitz MR; Wu X; Mills G
    J Clin Oncol; 2005 Jan; 23(2):267-75. PubMed ID: 15637390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.
    Verma M; Manne U
    Crit Rev Oncol Hematol; 2006 Oct; 60(1):9-18. PubMed ID: 16829121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children as a sensitive subpopulation for the risk assessment process.
    Preston RJ
    Toxicol Appl Pharmacol; 2004 Sep; 199(2):132-41. PubMed ID: 15313585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of breast cancer risk assessment.
    Hollingsworth AB; Nall S; Dill D
    J Okla State Med Assoc; 2002 Oct; 95(10):639-44. PubMed ID: 12420413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.